Continued treatment with AXS-05, a combination of dextromethorphan and bupropion, significantly reduces the risk for recurrence of Alzheimer’s disease–related agitation, phase 3 results show.

There are other patients.” One nurse described the intense effort to keep the agitated patient calm and not running down the stairwell. “But now there’s, you know, we have six staff members ...

Agitated patients are often prescribed antipsychotic medications and sedatives off-label, but this can pose a risk to the ...

Dancing is known to lift the spirit, and a new study shows that Alzheimer's disease patients respond to the rhythmic moves as well. Dance classes eased agitation in a small group of people with ...

Their most common features were agitation, irritability, pressured speech, and flight of ideas. Other researchers identified hypomanic features in 97 bipolar-II and 64 unipolar patients with major ...

Agitated Solutions receives IND application clearance from US FDA to begin phase 3 clinical trial for its novel contrast agent, ASI-02: St. Paul, Minn. Friday, April 11, 2025, 15: ...